Maintenance therapy involving a tapering dose of danazol or mid/low doses of oral contraceptive after gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain
article
OA: closed
CC0
⤵ 21 in-corpus citations
AI-generated summary
This study compared maintenance therapies with tapering danazol or oral contraceptives after GnRH agonist treatment for endometriosis-associated pelvic pain.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Pelvic pain associated with endometriosis was treated by the long-term administration of a tapering dose of danazol or mid/low doses of oral contraceptives after the end of therapy involving a GnRH agonist (GnRH-a). Results demonstrated that each of these three therapies is a practical and efficient treatment regimen to maintain the relief of pelvic pain achieved by GnRH-a therapy, at least for a period of 12 months.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (20)
- A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis via openalex
- Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen via openalex
- Danazol. A synthetic steroid with diverse biologic effects. via openalex
- Danazol inhibits steroidogenesis by the human ovary in vivo via openalex
- Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis via openalex
- Endometriosis: Treatment Strategies via openalex
- Expression of Aromatase Cytochrome P450 Protein and Messenger Ribonucleic Acid in Human Endometriotic and Adenomyotic Tissues but not in Normal Endometrium1 via openalex
- Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas via openalex
- Historical prospective cohort study of the recurrence of pain after discontinuation of treatment with danazol or a gonadotropin- releasing hormone agonist via openalex
- Postoperative administration of monophasic combined oral contraceptives after laparoscopic treatment of ovarian endometriomas: A prospective, randomized trial via openalex
- Treatment of deeply infiltrating endometriosis via openalex
- Usefulness and limits of CA-125 in diagnosis of endometriosis without associated ovarian endometriomas via openalex
- W4231406039 via openalex
- W1618997004 via openalex
- W2009102624 via openalex
- W2118946732 via openalex
- W2166744769 via openalex
- W2167428807 via openalex
- W2477008945 via openalex
- W10868991 via openalex
Cited by (21)
- Neuroimmunology of Endometriosis-Associated Pain and Its Psychological Aspects 2024
- A systematic literature review on patient-reported outcome domains and measures in nonsurgical efficacy trials related to chronic pain associated with endometriosis: an urgent call to action 2024
- Clinical practice guidelines for endometriosis in Japan (The 3rd edition) 2022
- Role of estrogen and estrogen-related factors in endometriosis 2021
- Medical treatment of endometriosis: is it a choice of the physician? 2020
- Hormonal contraception in women with endometriosis: a systematic review 2019
- Local estrogen formation and its regulation in endometriosis 2019
- Medical treatment of endometriosis-related pain 2018
- Management of Endometriosis: Toward Value-Based, Cost-Effective, Affordable Care 2017
- “Per vaginam” topical use of hormonal drugs in women with symptomatic deep endometriosis: a narrative literature review 2017
- Estrogen-progestins and progestins for the management of endometriosis 2016
- Vaginally Administered Danazol: An Overlooked Option in the Treatment of Rectovaginal Endometriosis? 2015
- Endometriosis still a challenge. 2014
- Systematic review of endometriosis pain assessment: how to choose a scale? 2014
- Evaluation of selected angiogenic and inflammatory markers in endometriosis before and after danazol treatment 2013
- Continuous use of oral contraceptives: an overview of effects and side‐effects 2012
- Antiproliferative and apoptotic effects of norethisterone on endometriotic stromal cells in vitro 2012
- Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain 2011
- Brief update on endometriosis treatment 2011
- Danazol falsely increased values in estradiol immunoassays 2010
- Is There a Role for Acupuncture in Endometriosis Pain, Or ‘endometrialgia’? 2008
Source provenance
- europepmc
- last seen: 2026-09-01T06:12:48.306406+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:14:48.452140+00:00
- unpaywall
- last seen: 2026-08-15T06:29:46.044917+00:00
License: CC0
· commercial use OK